A number of non-tuberculous mycobacterium species are opportunistic pathogens and
ubiquitously form biofilms. These infections are often recalcitrant to treatment and require …

Tuberculosis is a chronic disease that displays several features commonly associated with
biofilm-associated infections: immune system evasion, antibiotic treatment failures, and …

The role of biofilms in pathogenicity and treatment strategies is often neglected in
mycobacterial infections. In recent years, the emergence of nontuberculous mycobacterial …

The characterization of bacteria with hydrolytic potential significantly contributes to the
industries. Six cellulose-degrading bacteria were isolated from mixture soil samples …

Biofilm dispersal contributes to bacterial spread and disease transmission. However, its
exact mechanism, especially that in the pathogen Mycobacterium tuberculosis, is unclear. In …

Mycobacteria produce several unusual cofactors that contribute to their metabolic versatility
and capability to survive in different environments. Mycofactocin (MFT) is a redox cofactor …

Adhesion is crucial for the infective lifestyles of bacterial pathogens. Adhesion to non-living
surfaces, other microbial cells, and components of the biofilm extracellular matrix are crucial …

Abstract Background Mycobacterium tuberculosis (Mtb) forms physiologically relevant
biofilms harboring drug-tolerant bacteria. This observation has brought the study of …

There is good evidence that Mycobacterium tuberculosis evolved with Homo sapiens and,
like our ancestors, migrated throughout the rest of the world from Africa some 70,000 years …

Ethambutol (EMB) is a first-line antituberculosis drug currently being used clinically to treat
tuberculosis. Mutations in the embCAB operon are responsible for EMB resistance …